Nucleus Global
A senior leadership position in Nucleus Global’s medical communications team within the Inizio Medical network, supporting medical affairs clients across therapy areas globally. The role requires deep experience in scientific communications and engagement with pharmaceutical and life sciences clients.
Headquarters
London, England, United Kingdom
Company Size
501-1000 employees
Founded
1986
Nucleus Global is a pharmaceutical and medical communications agency that helps biotech, pharmaceutical and healthcare organisations share scientific and clinical evidence with stakeholders worldwide. They use a science‑first, evidence‑driven approach to deliver integrated services such as publications and medical affairs strategies, congress support, medical education, HEOR, and digital engagement across the product lifecycle. Cross‑functional teams of medical writers, strategists, creatives and digital specialists translate complex data into clear, compliant communications to support launches, uptake and ongoing stakeholder engagement. The agency emphasises bold strategic thinking and global reach to “share science with the world.”
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Nucleus Global.
Huntsworth adds Big Pharma-focused medical communications group Nucleus Global to its network
Nov 12, 2020
Associate Director, Scientific Communications Rare Disease
Kyowa Kirin
Senior Medical Writer
Ashfield MedComms
Associate Director, Medical Communications & Publications - Oncology
Ipsen
Director Business Development, Medical Affairs
Red Nucleus
Senior Manager/Associate Director, Scientific Communications
Avalyn Pharma
Director, Scientific Communications
Replimune